Gazzard, Brian; Hill, Andrew; Anceau, Anne - In: Applied Health Economics and Health Policy 9 (2011) 4, pp. 217-223
antiretrovirals taken after initial treatment failure. By this analysis, efficacy was 93.5% versus 95.1% in the DRV/r monotherapy and … annual cost of antiretrovirals was £6906 for patients receiving NNRTI-based HAART, and £8348 for patients receiving PI …-based HAART. During the MONET trial, the mean annual per-patient cost of antiretrovirals was £8642 in the triple therapy arm, of …